The 2023-2028 World Outlook for Blood Components and Plasma Products
This study covers the world outlook for blood components and plasma products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.
In this report we define the sales of blood components and plasma products as including all commonly understood products and/or services falling within this broad category, such as motor, electric drive, motion controller, and alternating current (AC) motor components; general motion (GMC) and computerized numerical (CNC) control technologies; and controls within the metal and machinery, semiconductor and electronic, and food and beverage industries, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include AABB, Abbott Laboratories, America`s Blood Centers, American Red Cross, America's Blood Centers, Beckman Coulter, Becton, Beijing Tiantan Biological Products Company, Bharat Serums and Vaccines, Bio Products Laboratory, Bio-Rad Laboratories, Biotest, Canadian Blood Services, Cerus, China Biologic Products, CSL Behring, Dickinson and Company, Fenwal, Fresenius Kabi, Grifols, Haemonetics, Huanlan Biological Engineering, Inc., Immucor, Japan Red Cross Society, Kawasumi Laboratories, Kedrion, LFB Group, MacoPharma, New York Blood Center, Octapharma, Ortho-Clinical Diagnostics, Sanquin Blood Supply Foundation, Shanghai RAAS Blood Products Company, Shire, Sichuan Yuanda Shuyang Pharmaceutical Company, and Terumo BCT. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook